Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Centrica (CNA.L)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (p) Price Target (p) Rating
2019-03-29114135Neutral
2019-04-18106110Neutral
2019-08-136568Neutral
2020-01-1388110Buy
2020-02-1182105Buy
2020-04-063130Neutral
2020-07-295050Neutral
2021-02-095360Neutral
2021-08-125057Neutral
2021-09-065256Neutral
2022-01-117475Neutral
2022-05-168090Neutral

Disclosures

  • UBS AG London Branch is acting as financial adviser to Centrica on the potential sale of its stake in British Energy
  • UBS Group AG, its affiliates or subsidiaries beneficially owned 1% or more of a class of this company`s common equity securities as of last month`s end (or the prior month`s end if this report is dated less than 10 days after the most recent month`s end).
  • UBS AG London Branch acts as broker to this company.
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.